Abstract P1-11-14: Efficacy and quality of life analysis of palonosetron vs ondansetron for high and moderate emetogenic chemotherapy for breast cancer

Autor: J Santamaría-Galicia, Nancy Reynoso-Noverón, O Macedo, J. L. Aguilar-Ponce, Juan Matus-Santos, Claudia Arce-Salinas, D. Flores-Díaz, JP Gonzalez-Serrano, Z Deneken-Hernandez, Erika Ruiz-García, G Calderillo-Ruiz

Publikováno v: Cancer Research. 79:P1-11

Background: Nausea and vomiting are common complications on the chemotherapy (CINV) and can affect the quality of life of the patients. There are various antiemetic regiments that varies in both cost and effectiveness. The aim of this trial is to eva

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fba3c02ea67c961623f895f9d921e29e
https://doi.org/10.1158/1538-7445.sabcs18-p1-11-14

Overweight and obesity as poor prognostic factors in locally advanced breast cancer patients

Autor: D. Flores-Díaz, A. Alvarado Miranda, D. Olvera-Caraza, Claudia Arce-Salinas, Alejandro Mohar, Fernando Lara-Medina, Cynthia Villarreal-Garza, J. L. Aguilar-Ponce

Publikováno v: Breast cancer research and treatment. 146(1)

Obesity and overweight are established risk factors for the development of breast cancer. They are also associated with poor prognosis for higher risk of disease recurrence and lower overall survival (OS). The aim of this study was to evaluate the in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1449d24a97ef9fb3ade9c32c6ab03e84
https://pubmed.ncbi.nlm.nih.gov/24842266

Bioavailability of etoposide after oral administration of the solution marketed for intravenous use: therapeutic and pharmacoeconomic perspectives

Autor: J L, Aguilar Ponce, Y, Flores-Picazo, J, Pérez-Urizar, G, Castañeda-Hernández, J W, Zinser-Sierra, A, Dueñas-González, E, Calderón-Flores, B A, Segura-Pacheco, J, de la Garza-Salazar

Publikováno v: Archives of medical research. 30(3)

Oral etoposide administration is a suitable alternative to the intravenous route; therefore, commercial capsules have been developed. Before these capsules were available in Mexico, we studied drug bioavailability after oral administration of the int

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b054a5371405dd78a55598dab8603667
https://pubmed.ncbi.nlm.nih.gov/10427872

Isolated limb perfusion with high-dose ifosfamide in the treatment of locally advanced sarcoma. A pilot study

Autor: Paula Cabrera, M. Cuellar, G. Rico, J.-L. Aguilar-Ponce, J. de la Garza, P. Alejandro, Carlos Lopez-Graniel, Héctor Martínez-Said

Publikováno v: Journal of Clinical Oncology. 23:9053-9053

9053 Background: Recent studies have evaluated the role of isolated limb perfusion (ILP) and hyperthermia in the management of extremity sarcoma. The agents most commonly employed for ILP have been...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::157ed28d848da1c0e83a2b1e4a276931
https://doi.org/10.1200/jco.2005.23.16_suppl.9053

Multi-Biomarker Profiling for Precision Diagnosis of Lung Cancer.

Autor: Seo D; Department of Bio-convergence Engineering, Korea University, Seoul, 02841, Republic of Korea.; Interdisciplinary Program in Precision Public Health, Korea University, Seoul, 02841, Republic of Korea., Choi BH; Department of Thoracic and Cardiovascular Surgery, College of Medicine, Korea University Guro Hospital, Korea University, Seoul, 08308, Republic of Korea.; Department of Biomedical Sciences, College of Medicine, Korea University, Seoul, 02841, Republic of Korea., La JA; Institute of Integrated Biotechnology, Sogang University, Seoul, 04107, Republic of Korea., Kim Y; Department of Chemical and Biomolecular Engineering, Sogang University, Seoul, 04107, Republic of Korea., Kang T; Institute of Integrated Biotechnology, Sogang University, Seoul, 04107, Republic of Korea.; Department of Chemical and Biomolecular Engineering, Sogang University, Seoul, 04107, Republic of Korea., Kim HK; Department of Thoracic and Cardiovascular Surgery, College of Medicine, Korea University Guro Hospital, Korea University, Seoul, 08308, Republic of Korea.; Department of Biomedical Sciences, College of Medicine, Korea University, Seoul, 02841, Republic of Korea., Choi Y; Department of Bio-convergence Engineering, Korea University, Seoul, 02841, Republic of Korea.; Interdisciplinary Program in Precision Public Health, Korea University, Seoul, 02841, Republic of Korea.; School of Biomedical Engineering, Korea University, Seoul, 02841, Republic of Korea.

Publikováno v: Small (Weinheim an der Bergstrasse, Germany) [Small] 2024 Nov; Vol. 20 (47), pp. e2402919. Date of Electronic Publication: 2024 Sep 02.